Provenance du réseau au premier degré de Thomas Ryll
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas Ryll via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Deluxe Business Operations, Inc.
 Deluxe Business Operations, Inc. Commercial Printing/FormsCommercial Services Deluxe Business Operations, Inc. used to design and produce printed products. The company products are business forms, checks, envelopes, labels and greeting cards, retail merchandising aids, packaging, shipping and warehouse supplies. The company was founded in 1952 and was headquartered in Groton, MA. | Commercial Printing/Forms | Director of Finance/CFO General Counsel Comptroller/Controller/Auditor | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Operating Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Public Communications Contact | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Director/Board Member | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member | |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Medical Specialties | Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Leeds | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree | |
| Colorado State University | College/University | Undergraduate Degree | |
| The University of Waterloo | College/University | Graduate Degree | |
| University of Massachusetts | College/University | Doctorate Degree Undergraduate Degree | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Public Communications Contact | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| CELYAD ONCOLOGY SA | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
New York Pharma Forum, Inc.
 New York Pharma Forum, Inc. Information Technology ServicesTechnology Services New York Pharma Forum, Inc. provides information technology services for the healthcare industry. The private company is based in New York, NY. | Information Technology Services | Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member | |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Medical/Nursing Services | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 39 |
| Royaume-Uni | 6 |
| Irlande | 2 |
| Canada | 2 |
| Belgique | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 76 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 38 |
| Undergraduate Degree | 18 |
| Chief Tech/Sci/R&D Officer | 17 |
Relations les plus connectées
| Insiders | |
|---|---|
| Howard H. Pien | 27 |
| Nicole Onetto | 17 |
| Mark Enyedy | 15 |
| Blaine McKee | 13 |
| Susan Altschuller | 12 |
| Jennifer Herron | 12 |
| David B. Johnston | 11 |
| Daniel Junius | 10 |
| Sandra E. Poole | 10 |
| Stuart Arbuckle | 10 |
| Charles Q. Morris | 10 |
| Joseph J. Villafranca | 9 |
| Stacy Coen | 9 |
| Helen Thackray | 8 |
| Richard Gregory | 8 |
- Bourse
- Insiders
- Thomas Ryll
- Connexions Sociétés
